To develop and validate a predictive model for radiotherapy-related genitourinary toxicity requiring hospital admission in patients with localized prostate cancer, enhancing clinical decision-making.
Key Findings:
Diabetes, smoking, and bladder outlet obstruction (BOO) without TURP were strong independent predictors of hospitalisation for genitourinary toxicity, highlighting the need for targeted interventions.
Patients with BOO without TURP had the lowest 10-year event-free survival rates (20%), indicating a critical area for clinical focus.
Baseline stress urinary incontinence was a significant predictor but was excluded from the final model due to multicollinearity, suggesting the need for careful variable selection in predictive modeling.
Interpretation:
The predictive model can help identify patients at high risk for genitourinary toxicity post-radiotherapy, potentially guiding clinical decision-making and patient management strategies.
Limitations:
The study is based on a single registry, which may limit generalizability to broader populations.
Potential for missing data and reliance on historical patient records may introduce bias, affecting the robustness of the findings.
Conclusion:
The developed model offers a valuable tool for predicting post-radiation genitourinary complications, aiding in the management of localized prostate cancer patients and improving patient outcomes.
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 16 - 28.